speb/financial-data huggingface dataset:
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 8100300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2293500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 114689400000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 1181600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 993600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 238900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 22692700000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 146900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 43270600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 19725200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1493100000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 119565000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 114928500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 109554900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 171170300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 116188000000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 14779000000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 119100800000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 52069500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 60077500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 10293500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 862700000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 69316800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 60452700000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 15856700000.00
ALKEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 129645200000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 31437500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 18393500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 18393500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 24662500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 24662500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -16703900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -16703900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -795400000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -795400000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Amortization: 283600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 283600000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 1346300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 1346300000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 8357800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 8357800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 119567114.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 119616738.00
ALKEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 181.11
ALKEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 25.57
ALKEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 663100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 14198800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 14198800000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -6756200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 3181100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3181100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 3041400000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3041400000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37779200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37779200000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -5046200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1073500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1073500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1967900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1967900000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -2612300000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 2166500000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -1935600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -2139700000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -1969100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 119848700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 119848700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 5456900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 5456900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 47642600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 12792800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 109458200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 109458200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 506900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 506900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 7518800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 7518800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 8025700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 8025700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 39649800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 39649800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 1591100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1591100000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 3571600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 3571600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 3571600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1124900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 3571600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1124900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 2244200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 2244200000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 119567114.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 119616738.00
ALKEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 181.11
ALKEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 25.57
ALKEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3058600000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1700000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 1700000.00
ALKEM.NS income_statement (annual, 2025-03-31) — EBIT: 26487300000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 4247600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — EBITDA: 30058900000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 5372500000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 105100000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: -1200900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2004700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2004700000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -8109900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 18664900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 18664900000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 12372200000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -530600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -46000000.00
ALKEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 3169800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Goodwill: 4231100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 4231100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 5376800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5376800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 25457900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 25457900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 46022600000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 46022600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 82002600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 18644700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 7103900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 7103900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 137300000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 1217000000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 284200000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1217000000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 284200000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Interest Income: 3587800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 3587800000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -806100000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 3477100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 29224100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 29224100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 130476600000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 130476600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -12987600000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 10362500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 10362500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 323800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 323800000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 2879000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1518900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1518900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 2674200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2674200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 3109100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3109100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5783300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5783300000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2879000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 323800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 323800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 3382200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3382200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 24848000000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 24848000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 4487600000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 4487600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Minority Interests: -499000000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -165300000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -330000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 7586500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 7586500000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 111600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income: 3058600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3058600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 22153800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3223900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3058600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3058600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 25270300000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 22153800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3223900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1217000000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -284200000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -9788600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -1941100000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 2879000000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1217000000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -284200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 29318700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 29318700000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -6347800000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -4820100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 114471900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 114471900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 219500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 219500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 17382500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 17382500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3382200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3382200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 3743100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 3743100000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 30058900000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 5372500000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 21654800000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 3058600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 19128400000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Operating Income: 21549900000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 2788000000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 129645200000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 31437500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 185400000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 185400000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 3057000000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 3057000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 361500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 361500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1145700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1145700000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -2525900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -300000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 219500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 219500000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 4937400000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1459600000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 32341900000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 8568300000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 4962700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 4962700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 23861500000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 23861500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1286300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1286300000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 34737800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 34737800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: -46000000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Payables: 23968900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 23968900000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1591100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1591100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 7742200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 7742200000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 25270300000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 3963400000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 153900000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -330000000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -56939200000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -6756200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 9265900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 9265900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 47642600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 12792800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 3571600000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1124900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 100800000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 100800000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -4820100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 7232200000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 7232200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 99730100000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 99730100000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 47150600000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 408400000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 12931300000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 16101100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 119565000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 119565000.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -4820100000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ALKEM.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 166100000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 119848700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 119848700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 114471900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 114471900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ALKEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 3110300000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 733300000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.12
ALKEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
ALKEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -5040200000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 176911000000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 176911000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 122957800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 122957800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 13809000000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 13809000000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 124336300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 124336300000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 108095300000.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 28649500000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 52574700000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 52574700000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 67452800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 67452800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 12924900000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 12924900000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 344600000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 611000000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 611000000.00
ALKEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ALKEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 19800000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 19800000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 1293300000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 1293300000.00
ALKEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 69808400000.00
ALKEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 69808400000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 15486100000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 33711400000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 119557235.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 55.56
ALKEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11711600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 876800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 876800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 119557235.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 55.56
ALKEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 6642600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 8007900000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 8884700000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 21999800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 297800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 297800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -36500000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 6642600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 6642600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 6679100000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 6642600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 6642600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 6679100000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -297800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -297800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 8755400000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 6530521329.17
ALKEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 6513700000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 33711400000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1364900000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 7676800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Other Special Charges: -129300000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 7710100000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11711600000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 876800000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 129300000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 17221329.17
ALKEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 1026900000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.13
ALKEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 27197700000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 129300000.00
ALKEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 129300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 17728000000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 40009900000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18866900000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 30915200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 21214000000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 119559306.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 63.99
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3935200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2261000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 51520400000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 133459800000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 6526800000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 14010300000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 121260500000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 547200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 14936400000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 15483600000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 48780100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 1733800000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 936100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 936100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 119559306.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 63.99
ALKEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 9308500000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 10244600000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 4969700000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 8336800000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 31381000000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 25999600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 350200000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 350200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 30073600000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 153080600000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 21214000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 314800000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3388000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4684400000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8072400000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 314800000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 3525300000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 4649500000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -140500000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 17359800000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 7791100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 7791100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -350200000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -350200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 31381000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 125123000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 18188300000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 157300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 10244600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 7650600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 8271600000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 40009900000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 8648300000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 3313900000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 133220700000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3367100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1400200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 200100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1036900000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 9689400000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 24854200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 103000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 49259400000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 20460000000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 8958300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 14010300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 936100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 119565000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 133459800000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 125123000000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 1162300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.13
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 202874500000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 138144200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 23556000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 138109300000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 31738300000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 64765200000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 81614000000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 15985100000.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1593100000.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
ALKEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ALKEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 72480400000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 17311200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 37368200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 119575108.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 53.19
ALKEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 12727100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 950100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 950100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 119575108.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 53.19
ALKEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 6360200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 8233000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 9183100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 24641100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 421000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 421000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -170100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 6360200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 6360200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 6530300000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6360200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6360200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 6530300000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -421000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -421000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 9711000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 6801826327.44
ALKEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 7329900000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 37368200000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1431000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 9146000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 7812000000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 12727100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 950100000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -527900000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -86273672.56
ALKEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1276700000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
ALKEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 30038300000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -527900000.00
ALKEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -527900000.00
ALKEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 69963500000.00
ALKEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 19438200000.00
ALKEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 147122700000.00
ALKEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 36033200000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 22441800000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 22441800000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 29791100000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 29791100000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 0.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 23124300000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 23124300000.00
ALKEM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 119567815.00
ALKEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 119605463.00
ALKEM.NS income_statement (annual, 2026-03-31) — Basic EPS: 192.51
ALKEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 19.77
ALKEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: -1200900000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -6172600000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 4236600000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 4236600000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2479100000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2479100000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 49927300000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 49927300000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -6137000000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -2473100000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 1214200000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -4164100000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -4151700000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -2075800000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 138201000000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 138201000000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1379100000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1379100000.00
ALKEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 50927700000.00
ALKEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 12478700000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 122105200000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 122105200000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 468800000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 468800000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 11310500000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 11310500000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 11779300000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 11779300000.00
ALKEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 47827000000.00
ALKEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 47827000000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 3820600000.00
ALKEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 3820600000.00
ALKEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 3820600000.00
ALKEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1057600000.00